Lead optimization of a novel series of imidazo[1,2-a]pyridine amides leading to a clinical candidate (Q203) as a multi- and extensively-drug-resistant anti-tuberculosis agent (Q42213423)
Jump to navigation
Jump to search
scientific article published on 17 June 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lead optimization of a novel series of imidazo[1,2-a]pyridine amides leading to a clinical candidate (Q203) as a multi- and extensively-drug-resistant anti-tuberculosis agent |
scientific article published on 17 June 2014 |
Statements
1 reference
Lead optimization of a novel series of imidazo[1,2-a]pyridine amides leading to a clinical candidate (Q203) as a multi- and extensively-drug-resistant anti-tuberculosis agent (English)
1 reference
Sunhee Kang
1 reference
Ryang Yeo Kim
1 reference
Min Jung Seo
1 reference
Saeyeon Lee
1 reference
Young Mi Kim
1 reference
Mooyoung Seo
1 reference
Jeong Jea Seo
1 reference
Yoonae Ko
1 reference
Inhee Choi
1 reference
Jichan Jang
1 reference
Jiyoun Nam
1 reference
Seijin Park
1 reference
Hwankyu Kang
1 reference
Hyung Jun Kim
1 reference
Jungjun Kim
1 reference
Sujin Ahn
1 reference
Kevin Pethe
1 reference
Kiyean Nam
1 reference
Zaesung No
1 reference
Jaeseung Kim
1 reference
17 June 2014
1 reference
1 reference
57
1 reference
12
1 reference
5293-5305
1 reference
Identifiers
1 reference
1 reference